Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 2/20 | 0.45 |
| ▸ | CHRM1 known ✓ | P11229 | 2/20 | 0.45 |
| ▸ | ACHE known ✓ | P22303 | 2/20 | 0.45 |
| ▸ | SLC6A2 known ✓ | P23975 | 2/20 | 0.45 |
| ▸ | SLC6A3 known ✓ | Q01959 | 2/20 | 0.45 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | CASP2 | P42575 | 1/20 | 0.48 |
| ▸ | RAD52 | P43351 | 3/20 | 0.47 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.47 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.45 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3028805 | 1.00 | KMT2A (0.48) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| Hydrochloric Acid SCHEMBL28410655 | 1.00 | KMT2A (0.48) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| SCHEMBL27656267 | 0.98 | CHRM2 (0.47) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| Hydrochloric Acid SCHEMBL28065870 | 0.98 | KMT2A (0.45) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| SCHEMBL2563316 | 0.98 | CHRM2 (0.47) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| SCHEMBL1168955 | 0.98 | CHRM2 (0.47) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| Bromide SCHEMBL28419938 | 0.96 | RAD52 (0.48) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| Bromide SCHEMBL28845552 | 0.96 | RAD52 (0.48) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| Bromide SCHEMBL28779518 | 0.96 | CHRM2 (0.45) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| SCHEMBL27656272 | 0.96 | CHRM2 (0.43) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3664776-B1 | APTAMERS FOR CONSUMER PRODUCT COMPOSITIONS | PROCTER & GAMBLE (US) | 2025-05-14 | — | — | EP | disclosed |
| WO-2025093061-A1 | COMPLEX FOR BLOCKING DENTINAL TUBULES, REAGENT FOR TREATING DENTIN HYPERSENSITIVITY, AND USE THEREOF | 安徽医科大学 | 2025-05-08 | — | — | WO | disclosed |
| US-10695281-B2 | Late stage addition of rheology modifier | THE PROCTER & GAMBLE COMPANY (US) | 2020-06-30 | — | — | US | disclosed |
| EP-3665282-A1 | APTAMERS FOR ORAL CARE APPLICATIONS | THE PROCTER & GAMBLE COMPANY (US) | 2020-06-17 | — | — | EP | disclosed |
| EP-3664776-A1 | APTAMERS FOR CONSUMER PRODUCT COMPOSITIONS | The Procter and Gamble Company (US) | 2020-06-17 | — | — | EP | disclosed |
| US-10676748-B2 | Aptamers for consumer product compositions | THE PROCTER & GAMBLE COMPANY (US) | 2020-06-09 | — | — | US | disclosed |
| CN-111050745-A | Nucleic acid ligands for consumer product compositions | 宝洁公司 | 2020-04-21 | — | — | CN | disclosed |
| US-20190091126-A1 | LATE STAGE ADDITION OF RHEOLOGY MODIFIER | PROCTER & GAMBLE (US) | 2019-03-28 | — | — | US | disclosed |
| WO-2019032811-A1 | APTAMERS FOR CONSUMER PRODUCT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2019-02-14 | — | — | WO | disclosed |
| US-20190048349-A1 | APTAMERS FOR ORAL CARE APPLICATIONS | NEOVENTURES BIOTECHNOLOGY INC. (CA) | 2019-02-14 | — | — | US | disclosed |
| WO-1996034592-A1 | DENTIFRICE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-11-07 | — | — | WO | disclosed |
| WO-1996034595-A1 | SILICA ABRASIVE COMPOSITIONS | J.M. HUBER CORPORATION (US) | 1996-11-07 | — | — | WO | disclosed |
| WO-1996034594-A1 | DENTIFRICE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-11-07 | — | — | WO | disclosed |
| WO-1996034593-A1 | DENTIFRICE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-11-07 | — | — | WO | disclosed |
| US-5560905-A | A TOOTHPASTE COMPRISING A SARCOSINATE SURFACTANT, A CHELATING TARTARIC ACID, ENDOGLYCOSIDASE, COCOAMIDOPROPYLBETAINE AND SODIUM FLUORIDE; ANTIPLAQUE,-GINGIVITIS AND -TARTAR AGENTS; REDUCED DESQUAMATION | THE PROCTOR & GAMBLE COMPANY (US) | 1996-10-01 | — | — | US | disclosed |
| WO-1996009809-A1 | DENTIFRICE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-04-04 | — | — | WO | disclosed |
| WO-1996008232-A1 | ORAL COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-03-21 | — | — | WO | disclosed |
| WO-1995031175-A1 | ORAL COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1995-11-23 | — | — | WO | disclosed |
| WO-1995031174-A1 | ORAL COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1995-11-23 | — | — | WO | disclosed |
| US-5338537-A | Antitartar ang antigingivitis agents | THE PROCTER & GAMBLE COMPANY (US) | 1994-08-16 | — | — | US | disclosed |